University of Bern establishes a multidisciplinary center for research into infectious diseases and immunity

The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years

21 Jan 2021
Diane Li
Assistant Editor

Industry news

Despite widespread warnings from the WHO in 2019 about the risks and the prediction of a “disease X”, the COVID-19 pandemic caught the world completely off guard. This event has demonstrated the sensitivity to epidemics and pandemics from interdependency of societies, as infectious pathogens have the capability of posing an existential threat to the world’s population, nations, economy and science in a globalized era. “The current crisis provides an impressive demonstration of the extent to which science is required to work in an interdisciplinary manner to analyze the problems that arise and to develop socially-relevant approaches for resolving them,” explains Christian Leumann, Rector of the University of Bern. “That is why, with generous financial support from the Vinetum Foundation, the University of Bern is establishing a much-needed research center to foster interdisciplinary research into future epidemics and pandemics to better fight and protect against them.”

In-depth expertise locally at hand

“The University of Bern has strong key competencies in areas most relevant in the current context of the COVID-19 pandemic,” explains Daniel Candinas, Vice-Rector for Research at the University of Bern. Outstanding and internationally-acknowledged research central to understand and overcome the pandemic is already being carried out in the areas of medicine, veterinary medicine, economics, political science, psychology and the humanities, for example. This expertise is now to be brought together at a multidisciplinary competence center for infectious diseases, immunity and their consequences (Multidisciplinary Center for Infectious Diseases and Immunity, MCIDI). “The MCIDI will explore pandemics from A to Z – from how they arise and how they are dealt with in the field of health care, through to the economic, political and ethical consequences,” explains Candinas. The newly-established center will benefit from the existing medical and veterinary network in Bern which is available for teaching and research (university institutes, clinics, laboratories and others), and from its proximity to the decision-making, political institutions.

Considerable support from the Vinetum Foundation

The Vinetum Foundation is a long-standing supporter of the University of Bern, and already backs research in the field of bee health. Franziska Borer Winzenried, President of the Vinetum Foundation and Honorary Doctor at the University of Bern: “We have confidence in the capabilities of the University of Bern demonstrated through its excellent research track record. We want to make our own contribution into the research of infectious diseases, because infectious diseases are on the rise – and the next dangerous pathogen is inevitable. We therefore need to take action against it now.” In this respect, having a global outreach is important, emphasizes Borer Winzenried: “The question of how we can best protect people in countries that have inadequate health systems is also very important.”

The “One Health” approach

The new research center is to consist of seven topic clusters to address medical and veterinary factors as well as issues surrounding economics, legal aspects and follow-on consequences investigated by methods from the social sciences. The “One Health” approach of the MCIDI, which examines the interactions between human, animal and environmental health, makes the affiliation with the Vetsuisse Faculty a natural fit. David Spreng, Dean of the Vetsuisse Faculty: “In the past year, not only has excellent research into COVID-19 been carried out in the area of One Health, but also in veterinary infectiology, when we proved able to develop the world’s first synthetic clone of Sars-CoV-2, for example.” This clone, which was also of interest to the WHO, is now being used by research groups worldwide to find antiviral drugs and develop vaccines.

The MCIDI was founded on January 1, 2021, and is being led by virologist Volker Thiel, head of virology at the Institute of Virology and Immunology and professor in Virology at the Vetsuisse Faculty, in its initial phase of the first four years. “I am looking forward to leading this interdisciplinary network with outstanding researchers and experts. It is important to learn from the experience of the pandemic in order to be better prepared for the scientific, societal and economic challenges in the future", says Thiel.

The MCIDI has been organized as a virtual center, so the creation of initial infrastructure is not necessary. This format has already proven successful for other interdisciplinary research centers, such as the Oeschger Center for Climate Research of the University of Bern.

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Tags

Combinatorial ChemistryCombinatorial chemistry, also known as combichem, is a technique used in drug discovery to create libraries of structurally related compounds. A library is generated by synthesis with a chemical reactor system or by computer-based modeling of compound combinations. When undertaking combinatorial chemistry consider reagents, buffers, resins and standards.Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.Cellular PathologyCellular Pathology deals with the microscopic analysis of tissue samples and cells. Sample preparation and processing includes fixation, staining, sectioning and slide mounting, using equipment such microtomes and cryostats. In choosing immunohistochemistry and immunocytochemistry kits, consider chromogens, staining method, antibodies, microscopes and imaging.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Clinical MicrobiologyMicrobiology is the study of microorganisms including protists, prokaryotes, fungi, and, often, viruses. Microorganisms are a useful research tool as genetic vectors and, in immunology, for antibiotic susceptibility testing, cellular biology and genetics. Microorganisms commonly grow readily in incubators with microbial culture media; this can contain chromogenic supplements to differentiate between cell lines. Estimate your culture’s density of microorganisms with colony counters, or screen and select colonies for desirable clones with automated colony pickers. Additionally, equipment is available to monitor environments for the presence of microbes and identify with microbial identification instruments. Find the best microbiology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Drug DeliveryDrug Delivery refers to dosage form, route of administration, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via the biopharmaceutical or small molecule drug's formulation, but it may also involve medical devices or drug-device combination products. Considerations include instrumentation, software and services. Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.TherapeuticsTherapeutics are treatments designed to alleviate or cure diseases. These include pharmaceuticals, biologics, and gene therapies, which work by targeting specific disease mechanisms. Advances in personalized medicine and biologics offer new hope for patients with conditions that were previously difficult to treat. Browse our peer-reviewed product directory to find therapeutic solutions for various diseases; compare products, check user reviews, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.CoronavirusCoronaviruses are a large family of viruses that can cause illnesses ranging from the common cold to more severe diseases like COVID-19. Research into the biology, transmission, and treatment of coronaviruses has become a global priority, particularly since the emergence of SARS-CoV-2. Understanding the virus�s structure and behavior is essential for developing vaccines, diagnostics, and antiviral treatments. Explore our peer-reviewed product directory to discover the latest research tools, diagnostic tests, vaccines, and treatments for coronavirus, compare products, read reviews, and receive pricing directly from manufacturers.Covid-19COVID-19, caused by the SARS-CoV-2 virus, has led to a global health crisis with profound impacts on societies and economies. Research into diagnostics, vaccines, treatments, and understanding viral mechanisms continues to evolve. The pandemic has accelerated innovations in healthcare and biopharmaceuticals, including novel vaccine platforms and rapid testing technologies. Browse our peer-reviewed product directory to find top COVID-19 testing kits, research tools, vaccines, and treatments, compare products, read reviews, and receive direct pricing from manufacturers.Infectious DiseasesInfectious diseases are caused by pathogens such as bacteria, viruses, and fungi. Effective detection, prevention, and treatment are crucial to control outbreaks and improve public health. Diagnostic tools, vaccines, and antimicrobial treatments are essential components of managing these diseases. Research into emerging pathogens and resistance patterns continues to evolve. Browse our peer-reviewed product directory to find the best diagnostic tools, prevention solutions, and treatment options; compare products, read customer reviews, and get pricing directly from manufacturers.
University of Bern establishes a multidisciplinary center for research into infectious diseases and immunity